Disclaimer

Placental Allografts – Website Content (PM)

Russell Health Intellectual Property Compliance Checklist

See full disclosure of uses of Russell Health’s intellectual property on your Account Setup & Licensing Agreement.

  • Placental Allografts Disclaimer must be placed on each webpage or marketing material. See Placental Allografts Disclaimer document.
  • No claims or additional language can be stated or marketed in anyway on marketing materials or webpage.
  • The following link must be placed on your webpage: https://www.rt4all.com/

Overview of Placental Tissue

The placenta is a maternal-fetal organ that develops from the fetus and attaches to the uterus during pregnancy. The placenta is responsible for, among other things, providing the growing fetus with oxygen and nutrients while at the same time removing toxins.1 It also serves as a barrier between maternal and fetal compartments. Once the baby is born, the placenta detaches from the uterine wall and is expelled from the body. Placental tissue can be harvested after a healthy, concluded birth and then processed into a human, placental tissue allograft.

Acellular Placental ECM Tissue Allografts

An acellular, placental extracellular matrix allograft is a soft connective tissue graft generated by a decellularization4 process that preserves the intact extracellular placental matrix. Upon implantation, this structure may serve as a scaffold to support the repair, reconstruction, replacement, or supplementation of the patient’s own tissue.5

Placental Tissues are FDA Regulated

Placental-derived tissue is regulated by the FDA under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Click on the following link to learn more about Placental Allografts: https:// www.rt4all.com/

  • THE FOLLOWING PLACENTAL TISSUE DISCLAIMER MUST BE PLACED ON THE BOTTOM OF ALL WEBPAGE AND/OR MARKETING MATERIAL.

Placental Allografts – Website Content (PM)

  • THE FOLLOWING PLACENTAL TISSUE DISCLAIMER MUST BE PLACED ON THE BOTTOM OF ALL WEBPAGE AND/OR MARKETING MATERIAL.

Placental Allografts Disclaimer

Disclaimer: Certain placental allografts consist of acellular, minimally manipulated tissues intended for homologous use to supplement patient’s own tissue. Tissue allografts are classified by the Food and Drug Administration (FDA) as Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public Health Service (PHS) Act. As an HCT/P regulated solely under the Section 361 of the PHS Act, tissue allografts are exempt from FDA pre-market review, clearance, and approval from FDA. Please consult your doctor to see if a tissue allograft is right for you. No medical advice has been offered herein. None of the statements in this brochure have been evaluated by the FDA. Placental-derived allografts are not intended to diagnose, treat, cure or prevent any disease and should not be used for the treatment of COVID-19.